Alberto Priori

Last updated
Priori, A. (2021). Priori, Alberto (ed.). Neurology of COVID-19. doi:10.54103/milanoup.57. ISBN   979-12-80325-35-8. PMID   35507705.
  • Ferrucci, Roberta; Demartini, Benedetta; Reitano, Maria Rita; Ruggiero, Fabiana; Nisticò, Veronica; Alberto, Priori (2021). Durante un'epidemia. Aspetti psicologici e psicopatologici legati alla pandemia di Covid-19[During an epidemic: Psychological and psychopathological aspects related to the Covid-19 pandemic] (in Italian). Erickson. ISBN   978-88-590-2541-2.
  • Selected articles

    • Priori, A.; Berardelli, A.; Inghilleri, M.; Accornero, N.; Manfredi, M. (1994). "Motor cortical inhibition and the dopaminergic system: Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism". Brain. 117 (2): 317–323. doi:10.1093/brain/117.2.317. PMID   8186958.
    • Priori, Alberto; Berardelli, Alfredo; Rona, Sabine; Accornero, Neri; Manfredi, Mario (July 1998). "Polarization of the human motor cortex through the scalp". NeuroReport. 9 (10): 2257–2260. doi:10.1097/00001756-199807130-00020. PMID   9694210.
    • Priori, Alberto (April 2003). "Brain polarization in humans: a reappraisal of an old tool for prolonged non-invasive modulation of brain excitability". Clinical Neurophysiology. 114 (4): 589–595. doi:10.1016/S1388-2457(02)00437-6. PMID   12686266.
    • Priori, Alberto; Lefaucheur, Jean-Pascal (March 2007). "Chronic epidural motor cortical stimulation for movement disorders". The Lancet Neurology. 6 (3): 279–286. doi:10.1016/S1474-4422(07)70056-X. PMID   17303534.
    • Priori, Alberto; Foffani, Guglielmo; Rossi, Lorenzo; Marceglia, Sara (July 2013). "Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations". Experimental Neurology. 245: 77–86. doi:10.1016/j.expneurol.2012.09.013. PMID   23022916.

    Related Research Articles

    <span class="mw-page-title-main">Transcranial magnetic stimulation</span> Brain stimulation using magnetic fields

    Transcranial magnetic stimulation (TMS) is a noninvasive form of brain stimulation in which a changing magnetic field is used to induce an electric current at a specific area of the brain through electromagnetic induction. An electric pulse generator, or stimulator, is connected to a magnetic coil connected to the scalp. The stimulator generates a changing electric current within the coil which creates a varying magnetic field, inducing a current within a region in the brain itself.

    <span class="mw-page-title-main">Deep brain stimulation</span> Neurosurgical treatment involving implantation of a brain pacemaker

    Deep brain stimulation (DBS) is a surgical procedure that implants a neurostimulator and electrodes which sends electrical impulses to specified targets in the brain responsible for movement control. The treatment is designed for a range of movement disorders such as Parkinson's disease, essential tremor, and dystonia, as well as for certain neuropsychiatric conditions like obsessive-compulsive disorder (OCD) and epilepsy. The exact mechanisms of DBS are complex and not entirely clear, but it is known to modify brain activity in a structured way.

    Neurotechnology encompasses any method or electronic device which interfaces with the nervous system to monitor or modulate neural activity.

    <span class="mw-page-title-main">Minimally conscious state</span> Disorder of Consciousness where overt signs of awareness are preserved

    A minimally conscious state or MCS is a disorder of consciousness distinct from persistent vegetative state and locked-in syndrome. Unlike persistent vegetative state, patients with MCS have partial preservation of conscious awareness. MCS is a relatively new category of disorders of consciousness. The natural history and longer term outcome of MCS have not yet been thoroughly studied. The prevalence of MCS was estimated to be 9 times of PVS cases, or between 112,000 and 280,000 in the US by year 2000.

    <span class="mw-page-title-main">Hypokinesia</span> Decreased movement due to basal ganglia dysfunction

    Hypokinesia is one of the classifications of movement disorders, and refers to decreased bodily movement. Hypokinesia is characterized by a partial or complete loss of muscle movement due to a disruption in the basal ganglia. Hypokinesia is a symptom of Parkinson's disease shown as muscle rigidity and an inability to produce movement. It is also associated with mental health disorders and prolonged inactivity due to illness, amongst other diseases.

    Neurohacking is a subclass of biohacking, focused specifically on the brain. Neurohackers seek to better themselves or others by “hacking the brain” to improve reflexes, learn faster, or treat psychological disorders. The modern neurohacking movement has been around since the 1980s. However, herbal supplements have been used to increase brain function for hundreds of years. After a brief period marked by a lack of research in the area, neurohacking started regaining interest in the early 2000s. Currently, most neurohacking is performed via do-it-yourself (DIY) methods by in-home users.

    <span class="mw-page-title-main">Transcranial direct-current stimulation</span> Technique of brain electric stimulation therapy

    Transcranial direct current stimulation (tDCS) is a form of neuromodulation that uses constant, low direct current delivered via electrodes on the head. It was originally developed to help patients with brain injuries or neuropsychiatric conditions such as major depressive disorder. It can be contrasted with cranial electrotherapy stimulation, which generally uses alternating current the same way, as well as transcranial magnetic stimulation.

    In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief from the symptoms.

    <span class="mw-page-title-main">Responsive neurostimulation device</span> Category of medical devices that respond to signals in a patients body to treat disease

    Responsive neurostimulation device is a medical device that senses changes in a person's body and uses neurostimulation to respond in the treatment of disease. The FDA has approved devices for use in the United States in the treatment of epileptic seizures and chronic pain conditions. Devices are being studied for use in the treatment of essential tremor, Parkinson's disease, Tourette's syndrome, depression, obesity, and post-traumatic stress disorder.

    Ablative brain surgery is the surgical ablation by various methods of brain tissue to treat neurological or psychological disorders. The word "Ablation" stems from the Latin word Ablatus meaning "carried away". In most cases, however, ablative brain surgery does not involve removing brain tissue, but rather destroying tissue and leaving it in place. The lesions it causes are irreversible. There are some target nuclei for ablative surgery and deep brain stimulation. Those nuclei are the motor thalamus, the globus pallidus, and the subthalamic nucleus.

    <span class="mw-page-title-main">Electrical brain stimulation</span> Form of electrotherapy

    Electrical brain stimulation (EBS), also referred to as focal brain stimulation (FBS), is a form of electrotherapy used as a technique in research and clinical neurobiology to stimulate a neuron or neural network in the brain through the direct or indirect excitation of its cell membrane by using an electric current. EBS is used for research or for therapeutic purposes.

    Neurostimulation is the purposeful modulation of the nervous system's activity using invasive or non-invasive means. Neurostimulation usually refers to the electromagnetic approaches to neuromodulation.

    Neurodegeneration with brain iron accumulation is a heterogenous group of inherited neurodegenerative diseases, still under research, in which iron accumulates in the basal ganglia, either resulting in progressive dystonia, parkinsonism, spasticity, optic atrophy, retinal degeneration, neuropsychiatric, or diverse neurologic abnormalities. Some of the NBIA disorders have also been associated with several genes in synapse and lipid metabolism related pathways. NBIA is not one disease but an entire group of disorders, characterized by an accumulation of brain iron, sometimes in the presence of axonal spheroids in the central nervous system.

    The temporal dynamics of music and language describes how the brain coordinates its different regions to process musical and vocal sounds. Both music and language feature rhythmic and melodic structure. Both employ a finite set of basic elements that are combined in ordered ways to create complete musical or lingual ideas.

    <span class="mw-page-title-main">Restorative neurology</span>

    Restorative neurology is a branch of neurology dedicated to improving functions of the impaired nervous system through selective structural or functional modification of abnormal neurocontrol according to underlying mechanisms and clinically unrecognized residual functions. When impaired, the body naturally reconstructs new neurological pathways and redirects activity. The field of restorative neurology works to accentuate these new pathways and primarily focuses on the theory of the plasticity of an impaired nervous system. Its main goal is to take a broken down and disordered nervous system and return it to a state of normal function. Certain treatment strategies are used to augment instead of fully replace any performance of surviving and also improving the potential of motor neuron functions. This rehabilitation of motor neurons allows patients a therapeutic approach to recovery opposed to physical structural reconstruction. It is applied in a wide range of disorders of the nervous system, including upper motor neuron dysfunctions like spinal cord injury, cerebral palsy, multiple sclerosis and acquired brain injury including stroke, and neuromuscular diseases as well as for control of pain and spasticity. Instead of applying a reconstructive neurobiological approach, i.e. structural modifications, restorative neurology relies on improving residual function. While subspecialties like neurosurgery and pharmacology exist and are useful in diagnosing and treating conditions of the nervous system, restorative neurology takes a pathophysiological approach. Instead of heavily relying on neurochemistry or perhaps an anatomical discipline, restorative neurology encompasses many fields and blends them together.

    Neuromodulation is "the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body". It is carried out to normalize – or modulate – nervous tissue function. Neuromodulation is an evolving therapy that can involve a range of electromagnetic stimuli such as a magnetic field (rTMS), an electric current, or a drug instilled directly in the subdural space. Emerging applications involve targeted introduction of genes or gene regulators and light (optogenetics), and by 2014, these had been at minimum demonstrated in mammalian models, or first-in-human data had been acquired. The most clinical experience has been with electrical stimulation.

    Gait variability seen in Parkinson's Disorders arise due to cortical changes induced by pathophysiology of the disease process. Gait rehabilitation is focused to harness the adapted connections involved actively to control these variations during the disease progression. Gait variabilities seen are attributed to the defective inputs from the Basal Ganglia. However, there is altered activation of other cortical areas that support the deficient control to bring about a movement and maintain some functional mobility.

    Non-invasive cerebellar stimulation is the application of non-invasive neurostimulation techniques on the cerebellum to modify its electrical activity. Techniques such as transcranial magnetic stimulation (TMS) or transcranial direct current stimulation (tDCS) can be used. The cerebellum is a high potential target for neuromodulation of neurological and psychiatric disorders due to the high density of neurons in its superficial layer, its electrical properties, and its participation in numerous closed-loop circuits involved in motor, cognitive, and emotional functions.

    <span class="mw-page-title-main">Friedhelm Hummel</span> German neuroscientist and neurologist

    Friedhelm Christoph Hummel is a German neuroscientist and neurologist. A full professor at École Polytechnique Fédérale de Lausanne, he is the Defitech Chair of Clinical Neuroengineering, and the head of the Hummel Laboratory at EPFL's School of Life Sciences. He also is an associate professor of clinical neuroscience at the University of Geneva.

    <span class="mw-page-title-main">Adaptive Deep Brain Stimulation</span> Neurosurgical treatment involving implantation of an adaptive neurostimularot

    Adaptive Deep Brain Stimulation (aDBS), also known as Closed Loop Deep Brain stimulation (clDBS), is a neuro-modulatory technique currently under investigation for the treatment of neurodegenerative diseases.

    References

    1. Talan, Jamie (27 March 2020). "COVID-19: Neurologists in Italy to Colleagues in US: Look for Poorly-Defined Neurologic Conditions in Patients with the Coronavirus". Neurology Today.
    2. 1 2 "Priori Alberto - Università degli Studi di Milano".
    3. "Alberto Priori – ResearchGate Profile".
    4. "2019-11-12 - Alberto Priori". NIMET: Nanoscience Institute for Medical & Engineering Technology.
    5. "Alberto Priori – IEEE Xplore".
    6. "Prof. Alberto Priori". www.asst-santipaolocarlo.it.
    7. Priori, Alberto; Berardelli, Alfredo; Rona, Sabine; Accornero, Neri; Manfredi, Mario (July 1998). "Polarization of the human motor cortex through the scalp". NeuroReport. 9 (10): 2257–2260. doi:10.1097/00001756-199807130-00020. PMID   9694210. S2CID   36460106.[ non-primary source needed ]
    8. Ferbert, A; Priori, A; Rothwell, J C; Day, B L; Colebatch, J G; Marsden, C D (July 1992). "Interhemispheric inhibition of the human motor cortex". The Journal of Physiology. 453 (1): 525–546. doi:10.1113/jphysiol.1992.sp019243. PMC   1175572 . PMID   1464843.[ non-primary source needed ]
    9. "Alberto Priori". scholar.google.it.
    10. "Loop | Alberto Priori". loop.frontiersin.org.
    11. "Newronika Interview".
    12. Priori, Alberto; Foffani, Guglielmo; Rossi, Lorenzo; Marceglia, Sara (July 2013). "Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations". Experimental Neurology. 245: 77–86. doi:10.1016/j.expneurol.2012.09.013. PMID   23022916. S2CID   37560257.[ non-primary source needed ]
    13. Arlotti, Mattia; Rosa, Manuela; Marceglia, Sara; Barbieri, Sergio; Priori, Alberto (July 2016). "The adaptive deep brain stimulation challenge". Parkinsonism & Related Disorders. 28: 12–17. doi:10.1016/j.parkreldis.2016.03.020. hdl:11585/570018. PMID   27079257.[ non-primary source needed ]
    14. Arlotti, Mattia; Rossi, Lorenzo; Rosa, Manuela; Marceglia, Sara; Priori, Alberto (May 2016). "An external portable device for adaptive deep brain stimulation (aDBS) clinical research in advanced Parkinson's Disease". Medical Engineering & Physics. 38 (5): 498–505. doi:10.1016/j.medengphy.2016.02.007. hdl: 11585/570013 . PMID   27029510.[ non-primary source needed ]
    15. Arlotti, Mattia; Marceglia, Sara; Foffani, Guglielmo; Volkmann, Jens; Lozano, Andres M.; Moro, Elena; Cogiamanian, Filippo; Prenassi, Marco; Bocci, Tommaso; Cortese, Francesca; Rampini, Paolo; Barbieri, Sergio; Priori, Alberto (13 March 2018). "Eight-hours adaptive deep brain stimulation in patients with Parkinson disease". Neurology. 90 (11): e971–e976. doi:10.1212/WNL.0000000000005121. PMC   5858949 . PMID   29444973.[ non-primary source needed ]
    16. Rosa, Manuela; Arlotti, Mattia; Marceglia, Sara; Cogiamanian, Filippo; Ardolino, Gianluca; Fonzo, Alessio Di; Lopiano, Leonardo; Scelzo, Emma; Merola, Aristide; Locatelli, Marco; Rampini, Paolo M.; Priori, Alberto (April 2017). "A daptive deep brain stimulation controls levodopa-induced side effects in P arkinsonian patients". Movement Disorders. 32 (4): 628–629. doi:10.1002/mds.26953. PMC   5412843 . PMID   28211585.[ non-primary source needed ]
    17. Bocci, T.; Prenassi, M.; Arlotti, M.; Cogiamanian, F. M.; Borellini, L.; Moro, E.; Lozano, A. M.; Volkmann, J.; Barbieri, S.; Priori, A.; Marceglia, S. (2021). "Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson's disease - PMC". npj Parkinson's Disease. 7 (1): 88. doi:10.1038/s41531-021-00229-z. PMC   8478873 . PMID   34584095.[ non-primary source needed ]
    18. Arlotti, Mattia; Colombo, Matteo; Bonfanti, Andrea; Mandat, Tomasz; Lanotte, Michele Maria; Pirola, Elena; Borellini, Linda; Rampini, Paolo; Eleopra, Roberto; Rinaldo, Sara; Romito, Luigi; Janssen, Marcus L. F.; Priori, Alberto; Marceglia, Sara (7 December 2021). "A New Implantable Closed-Loop Clinical Neural Interface: First Application in Parkinson's Disease". Frontiers in Neuroscience. 15. doi: 10.3389/fnins.2021.763235 . PMC   8689059 . PMID   34949982.[ non-primary source needed ]
    19. Nitsche, Michael A.; Cohen, Leonardo G.; Wassermann, Eric M.; Priori, Alberto; Lang, Nicolas; Antal, Andrea; Paulus, Walter; Hummel, Friedhelm; Boggio, Paulo S.; Fregni, Felipe; Pascual-Leone, Alvaro (July 2008). "Transcranial direct current stimulation: State of the art 2008". Brain Stimulation. 1 (3): 206–223. doi:10.1016/j.brs.2008.06.004. PMID   20633386. S2CID   16352598.[ non-primary source needed ]
    20. Brunoni, Andre Russowsky; Nitsche, Michael A.; Bolognini, Nadia; Bikson, Marom; Wagner, Tim; Merabet, Lotfi; Edwards, Dylan J.; Valero-Cabre, Antoni; Rotenberg, Alexander; Pascual-Leone, Alvaro; Ferrucci, Roberta; Priori, Alberto; Boggio, Paulo Sergio; Fregni, Felipe (July 2012). "Clinical research with transcranial direct current stimulation (tDCS): Challenges and future directions". Brain Stimulation. 5 (3): 175–195. doi:10.1016/j.brs.2011.03.002. PMC   3270156 . PMID   22037126.[ non-primary source needed ]
    21. Lefaucheur, Jean-Pascal; Antal, Andrea; Ayache, Samar S.; Benninger, David H.; Brunelin, Jérôme; Cogiamanian, Filippo; Cotelli, Maria; De Ridder, Dirk; Ferrucci, Roberta; Langguth, Berthold; Marangolo, Paola; Mylius, Veit; Nitsche, Michael A.; Padberg, Frank; Palm, Ulrich; Poulet, Emmanuel; Priori, Alberto; Rossi, Simone; Schecklmann, Martin; Vanneste, Sven; Ziemann, Ulf; Garcia-Larrea, Luis; Paulus, Walter (January 2017). "Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS)". Clinical Neurophysiology. 128 (1): 56–92. doi:10.1016/j.clinph.2016.10.087. hdl: 10067/1420300151162165141 . PMID   27866120. S2CID   4837447.[ non-primary source needed ]
    22. Woods, A.J.; Antal, A.; Bikson, M.; Boggio, P.S.; Brunoni, A.R.; Celnik, P.; Cohen, L.G.; Fregni, F.; Herrmann, C.S.; Kappenman, E.S.; Knotkova, H.; Liebetanz, D.; Miniussi, C.; Miranda, P.C.; Paulus, W.; Priori, A.; Reato, D.; Stagg, C.; Wenderoth, N.; Nitsche, M.A. (February 2016). "A technical guide to tDCS, and related non-invasive brain stimulation tools". Clinical Neurophysiology. 127 (2): 1031–1048. doi:10.1016/j.clinph.2015.11.012. PMC   4747791 . PMID   26652115.[ non-primary source needed ]
    23. Antal, A.; Alekseichuk, I.; Bikson, M.; Brockmöller, J.; Brunoni, A.R.; Chen, R.; Cohen, L.G.; Dowthwaite, G.; Ellrich, J.; Flöel, A.; Fregni, F.; George, M.S.; Hamilton, R.; Haueisen, J.; Herrmann, C.S.; Hummel, F.C.; Lefaucheur, J.P.; Liebetanz, D.; Loo, C.K.; McCaig, C.D.; Miniussi, C.; Miranda, P.C.; Moliadze, V.; Nitsche, M.A.; Nowak, R.; Padberg, F.; Pascual-Leone, A.; Poppendieck, W.; Priori, A.; Rossi, S.; Rossini, P.M.; Rothwell, J.; Rueger, M.A.; Ruffini, G.; Schellhorn, K.; Siebner, H.R.; Ugawa, Y.; Wexler, A.; Ziemann, U.; Hallett, M.; Paulus, W. (September 2017). "Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines". Clinical Neurophysiology. 128 (9): 1774–1809. doi:10.1016/j.clinph.2017.06.001. PMC   5985830 . PMID   28709880.[ non-primary source needed ]
    24. Ferrucci, Roberta; Dini, Michelangelo; Groppo, Elisabetta; Rosci, Chiara; Reitano, Maria Rita; Bai, Francesca; Poletti, Barbara; Brugnera, Agostino; Silani, Vincenzo; D’Arminio Monforte, Antonella; Priori, Alberto (13 February 2021). "Long-Lasting Cognitive Abnormalities after COVID-19". Brain Sciences. 11 (2): 235. doi: 10.3390/brainsci11020235 . PMC   7917789 . PMID   33668456.[ non-primary source needed ]
    25. Priori, A. (2021). Priori, Alberto (ed.). Neurology of COVID-19. doi:10.54103/milanoup.57. ISBN   979-12-80325-35-8. PMID   35507705.[ page needed ][ non-primary source needed ]
    26. Moro, E.; Priori, A.; Beghi, E.; Helbok, R.; Campiglio, L.; Bassetti, C. L.; Bianchi, E.; Maia, L. F.; Ozturk, S.; Cavallieri, F.; Zedde, M.; Sellner, J.; Bereczki, D.; Rakusa, M.; Di Liberto, G.; Sauerbier, A.; Pisani, A.; Macerollo, A.; Soffietti, R.; Taba, P.; Crean, M.; Twardzik, A.; Oreja-Guevara, C.; Bodini, B.; Jenkins, T. M.; von Oertzen, T. J.; EAN core COVID-19 Task, Force (September 2020). "The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection". European Journal of Neurology. 27 (9): 1727–1737. doi:10.1111/ene.14407. PMC   7323212 . PMID   32558002.{{cite journal}}: CS1 maint: numeric names: authors list (link)[ non-primary source needed ]
    27. Ferrucci, Roberta; Averna, Alberto; Marino, Daniela; Reitano, Maria Rita; Ruggiero, Fabiana; Mameli, Francesca; Dini, Michelangelo; Poletti, Barbara; Barbieri, Sergio; Priori, Alberto; Pravettoni, Gabriella (2 November 2020). "Psychological Impact During the First Outbreak of COVID-19 in Italy". Frontiers in Psychiatry. 11. doi: 10.3389/fpsyt.2020.559266 . PMC   7667038 . PMID   33240119.[ non-primary source needed ]
    28. Ferrarese, Carlo; Silani, Vincenzo; Priori, Alberto; Galimberti, Stefania; Agostoni, Elio; Monaco, Salvatore; Padovani, Alessandro; Tedeschi, Gioacchino; Italian Society of Neurology (June 2020). "An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID)". Neurological Sciences. 41 (6): 1355–1359. doi:10.1007/s10072-020-04450-1. PMC   7235538 . PMID   32430621.[ non-primary source needed ]
    Alberto Priori
    Alberto Priori academic.jpg
    Born (1962-11-19) November 19, 1962 (age 61)
    Nationality Italian
    Occupation(s)Neurologist, academic, and author
    Academic background
    Education Degree in Medicine and Surgery
    Specialization in Neurology
    Doctor of Philosophy (PhD)
    Alma mater University of Rome “La Sapienza”